Chronic Myelogenous Leukemia Presenting as a Secondary Malignancy After BCR-ABL1-negative B-lymphoblastic Leukemia/Lymphoma in a Pediatric Patient

被引：0

作者：

Popa, Gheorghe ^{[1
]}

Blag, Cristina ^{[1
]}

Olteanu, Horatiu ^{[2
]}

机构：

[1] Iuliu Hatieganu Univ Med & Pharm, Pediat Clin 2, Dept Pediat Oncol, Cluj Napoca, Romania

[2] Med Coll Wisconsin, Dept Pathol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA

来源：

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY | 2017年 / 20卷 / 01期

关键词：

chronic myelogenous leukemia; lymphoblastic leukemia/lymphoma; cytogenetics; flow cytometry; BCR-ABLI; CHRONIC MYELOID-LEUKEMIA; CHRONIC GRANULOCYTIC-LEUKEMIA; CHILDREN;

D O I：

10.1177/1093526616671047

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Chronic myelogenous leukemia, BCR-ABL1 positive (CML) is a rare myeloproliferative neoplasm in children and presents even less often as a secondary malignancy in the pediatric population. Below, we report a patient with Philadelphia-negative B-lymphoblastic leukemia/lymphoma, who developed CML several years after achieving complete remission, and summarize the existing literature on the clinical and pathologic features of CML as a secondary pediatric malignancy.

引用

页码：58 / 62

页数：5

共 50 条

[1] Chronic Myelogenous Leukemia, BCR-ABL1+
Vardiman, James W.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (02) : 250 - 260
[2] Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
Diamantopoulos, Panagiotis T.
Viniou, Nora-Athina
FRONTIERS IN ONCOLOGY, 2021, 11
[3] Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia
Chen, Zhining
Hu, Shimin
Wang, Sa A.
Konopleva, Marina
Tang, Zhenya
Xu, Jie
Li, Shaoying
Toruner, Gokce
Thakral, Beenu
Medeiros, L. Jeffrey
Tang, Guilin
LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2831 - 2838
[4] Near-triploidy with four Philadelphia chromosomes in adult B-lymphoblastic leukemia with BCR::ABL1 fusion
Yamamoto, Katsuya
Hirakawa, Yuri
Matsumoto, Sakuya
Yakushijin, Kimikazu
Minami, Hironobu
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (06) : 988 - 990
[5] BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use
Yenamandra, Ashwini K.
Kaviany, Saara
Borinstein, Scott C.
Friedman, Debra L.
Kovach, Alexandra E.
LABORATORY MEDICINE, 2019, 50 (04) : 401 - 405
[6] p210 BCR-ABL1 positive pediatric B-lineage acute lymphoblastic leukemia presenting with hypercalcemia
Bommannan, Karthik
Totadri, Sidharth
Sachdeva, Man Updesh Singh
Naseem, Shano
Trehan, Amita
Varma, Neelam
LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 501 - 502
[7] Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
Poonam, Jain P.
Mayur, Parihar
Rayaz, Ahmed
Aby, Abraham
Auro, Vishwabandya
Biju, George
Vikram, Mathews
Alok, Srivastava
Vivi, Srivastava M.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (03) : 347 - 351
[8] Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
Krumbholz, Manuela
Karl, Matthias
Tauer, Josephine T.
Thiede, Christian
Rascher, Wolfgang
Suttorp, Meinolf
Metzler, Markus
GENES CHROMOSOMES & CANCER, 2012, 51 (11) : 1045 - 1053
[9] The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis
Kim, Hyun-Young
Park, Silvia
Kim, Sun-Hee
Kim, Hee-Jin
BLOOD CELLS MOLECULES AND DISEASES, 2017, 65 : 68 - 70
[10] Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient
Zamecnikova, Adriana
Al Bahar, Soad
Pandita, Ramesh
HEMATOLOGY, 2012, 17 (06) : 321 - 324

← 1 2 3 4 5 →